Yubo International Biotech Limited
YBGJ
$0.01
$0.01120.41%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.06M | -916.20K | -1.08M | -1.11M | -1.41M |
| Total Depreciation and Amortization | 118.10K | 162.20K | 177.70K | 175.70K | 180.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -122.90K | -121.50K | -159.80K | -203.20K | -173.50K |
| Change in Net Operating Assets | 284.50K | 166.40K | 167.40K | -562.90K | 419.10K |
| Cash from Operations | -779.20K | -709.10K | -893.90K | -1.70M | -985.40K |
| Capital Expenditure | -- | 6.20K | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -79.90K | 0.00 | 0.00 | 79.90K | 116.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -79.90K | 6.20K | 0.00 | 79.90K | 116.40K |
| Total Debt Issued | 667.30K | 786.20K | 849.50K | 1.51M | 1.06M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 76.80K | 102.20K |
| Cash from Financing | 667.30K | 786.20K | 849.50K | 1.58M | 1.16M |
| Foreign Exchange rate Adjustments | 193.30K | -82.80K | 45.40K | 37.50K | -296.00K |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 1.50K | 500.00 | 1.00K | 2.90K | -2.30K |